Market Entry Models in Malaysia: Subsidiary, Independent AR or Dealer

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Three structures are available for entering the Malaysian market, and they differ on three axes that matter commercially: who holds the registration certificate, what the fixed cost base looks like, and how much control the manufacturer retains over the channel and the customer data. The subsidiary model, the independent AR model and the dealer model each solve a different problem, and the mistake is to select one on the convenience of a first order rather than on a multi-year plan.

  • Subsidiary. A local company is established, holds its own EL in an AR or importer capacity, and holds the registration certificate itself.
  • Independent AR. A professional AR holds the certificate, and the manufacturer builds or appoints its own distribution network.
  • Dealer. The dealer holds both the EL and the certificate, and the manufacturer supplies it indirectly.
  • Fixed cost is highest in the subsidiary model. Incorporation, the Person Responsible, premises, GDPMD certification, the EL fee and the official fees all sit with the manufacturer.
  • Control runs in the opposite direction to speed. Certificate and data control rank subsidiary first, independent AR second and dealer third; channel profit and localisation speed reverse that order.
  • Model migration is expensive. Moving between structures involves registration transfer or re-registration, so the decision should be taken against a three-year market plan.

2. Legal basis

The structures are all built from the same legal materials. Act 737 requires the establishment to hold an EL and the device to be registered, and the registration is held by whichever establishment applied for it. The MDA Licensing for Establishment guidance sets out the categories of establishment and the authorisation chain that connects them, including the LoA templates in Annex B. What differs between the three models is which entity occupies which position in that chain.

FeatureSubsidiaryIndependent ARDealer
EL holderLocal companyARDealer
Certificate holderLocal companyARDealer
Fixed costHighestModerateLowest upfront
Cost characterIncorporation, premises, GDPMD, EL fee, official feesService fee plus official feesMargin-based
Certificate controlHighestModerateLowest
Customer data controlHighestModerateLowest
Localisation speedSlowestModerateFastest
FlexibilityLowestHighestLowest

The subsidiary model carries the heaviest fixed cost because the manufacturer becomes the establishment. That means company incorporation, a Person Responsible meeting the senior management and citizenship or employment pass requirements, premises, GDPMD certification, the EL fee and the official registration fees. In exchange, the manufacturer holds the certificate and the customer relationship directly.

The independent AR model externalises the establishment function. The manufacturer pays a service fee plus the official fees, and gains the greatest flexibility, because the certificate sits with an entity whose role is to hold it rather than to sell. The dealer model is the lightest at the outset, since the dealer carries the licensing and registration burden, but it offers the weakest bargaining position and the least visibility of customer data.

Local manufacturing raises a separate layer of considerations. Where production is established in Malaysia, the incentives administered by MIDA become relevant, including instruments such as Pioneer Status and investment tax allowance arrangements that extend to medical device manufacturing. That is a distinct strategic decision requiring its own assessment, and it should not be conflated with the choice of market entry structure, even though the two interact.

3. Expert insights

The ranking that matters most is not cost but control, because control is what cannot be recovered later at a reasonable price. A subsidiary gives the manufacturer the certificate and the customer data, at the price of a permanent local cost base. An independent AR gives a middle position: the certificate is held by a party whose commercial interest is in holding it, and the distribution relationships remain the manufacturer’s to shape. A dealer gives speed and low upfront cost, and in exchange the certificate and the customer relationship sit with the counterparty.

The three questions that resolve most decisions are therefore sequential rather than financial. How long and how deeply does the manufacturer intend to operate in Malaysia? Is the channel likely to change during the life of the registration? Does the manufacturer need the certificate and the customer data in its own hands? Once those are answered, the cost comparison mostly confirms a conclusion that the strategic answers have already reached. Where the answers are genuinely unclear, the independent AR structure with flexible distribution is the sensible default, because it preserves optionality at a moderate cost.

The reason to decide early is that the cost of changing later is not a contract termination cost. It is a regulatory project: the certificate must be transferred or the device re-registered, and the EL arrangements must be adjusted to match. That work is measured in months and consumes management attention at precisely the moment when the commercial relationship has broken down. Organisations that select a structure for the convenience of the first order tend to pay for that convenience twice.

4. Practical recommendations

  • Set the decision horizon at three years, not at the first purchase order, and test each model against the channel plan for that period.
  • Where the portfolio is multi-SKU and the intention is long-term, favour the subsidiary or independent AR structures, since both keep the certificate within reach.
  • Where the exercise is a market test through a single channel, the dealer model can be appropriate, provided the exit and transfer mechanics are agreed before signature.
  • Price the subsidiary model on its full fixed cost base, including incorporation, the Person Responsible, premises, GDPMD certification and the EL fee, rather than on the official fees alone.
  • Treat local manufacturing incentives as a separate assessment. MIDA instruments such as Pioneer Status and investment tax allowance are relevant to a manufacturing decision, not to the choice of distribution structure.
  • Document the chosen structure and its rationale, so that a later proposal to change it is tested against the original assumptions rather than against convenience.

5. Verification checklist

  • □ Confirm the establishment categories and authorisation chain in the MDA Licensing for Establishment guidance.
  • □ Confirm the tax incentive position in the MIDA Guide on Medical Devices Industry in Malaysia, July 2020.
  • □ Confirm the division of regulatory responsibility described in the Chambers Global Practice Guide 2020, Malaysia chapter.
  • □ Confirm which entity currently holds each registration certificate before evaluating a change of structure.
  • □ Confirm that the chosen structure can satisfy the Person Responsible and GDPMD requirements before committing to it.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Malaysia. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with the MDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail